These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 14640009)

  • 21. K/DOQI gets to the heart of managing dyslipidemias in patients with CKD.
    Benner D
    Nephrol Nurs J; 2005; 32(3):337-8. PubMed ID: 16035475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CAN the new K/DOQI guidelines make a difference for the CKD patient.
    Fester S
    Nephrol News Issues; 2002 Apr; 16(5):27, 29. PubMed ID: 11962147
    [No Abstract]   [Full Text] [Related]  

  • 23. K/DOQI guidelines for bone metabolism and disease in chronic kidney disease patients: some therapeutic implications.
    Uribarri J;
    Semin Dial; 2004; 17(5):349-50. PubMed ID: 15461740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anaemia and mineral bone disorder in chronic kidney disease: a review of the current literature and implications for clinical nursing practice.
    Limrick C; McNichols-Thomas C
    J Ren Care; 2009 Mar; 35 Suppl 1():94-100. PubMed ID: 19222739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Executing change in the management of chronic kidney disease: perspectives on guidelines and practice.
    Levin A; Stevens LA
    Med Clin North Am; 2005 May; 89(3):701-9. PubMed ID: 15755474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Unawareness of the K/DOQI guidelines for bone and mineral metabolism in predialysis chronic kidney disease: results of the OSERCE Spanish multicenter-study survey].
    Bover J; Górriz JL; Martín de Francisco AL; Caravaca F; Barril G; Molinero LM;
    Nefrologia; 2008; 28(6):637-43. PubMed ID: 19016638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of mineral and bone disorders in patients on dialysis: a team approach to improving outcomes.
    Carver M; Carder J; Hartwell L; Arjomand M
    Nephrol Nurs J; 2008; 35(3):265-70. PubMed ID: 18649587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.
    Craver L; Marco MP; Martínez I; Rue M; Borràs M; Martín ML; Sarró F; Valdivielso JM; Fernández E
    Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practice guidelines do improve patient outcomes: association or causation?
    Levin A
    Blood Purif; 2008; 26(1):67-72. PubMed ID: 18182800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practice recommendations based on low, very low, and missing evidence.
    Coyne DW
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):11-2. PubMed ID: 17699379
    [No Abstract]   [Full Text] [Related]  

  • 31. Renal Association Clinical Practice Guideline in mineral and bone disorders in CKD.
    Steddon S; Sharples E
    Nephron Clin Pract; 2011; 118 Suppl 1():c145-52. PubMed ID: 21555893
    [No Abstract]   [Full Text] [Related]  

  • 32. Improving chronic kidney disease care in primary care practices: an upstate New York practice-based research network (UNYNET) study.
    Fox CH; Swanson A; Kahn LS; Glaser K; Murray BM
    J Am Board Fam Med; 2008; 21(6):522-30. PubMed ID: 18988719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nephrology evidence and guidelines: current tools and several still open questions].
    Strippoli GF; Manno C; Schena FP
    G Ital Nefrol; 2003; 20(3):271-9. PubMed ID: 12881850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [K/DOQI clinical practice guidelines for bone metabolism and disease in CKD].
    Sakaguchi T; Akizawa T
    Clin Calcium; 2004 Sep; 14(9):9-14. PubMed ID: 15577103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CE: Continuing Education article. Patient management in CKD stages 1 TO 3.
    Murphy F; Jenkins K; Chamney M; McCann M; Sedgewick J
    J Ren Care; 2008 Sep; 34(3):127-35. PubMed ID: 18786079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Appraisal of evidence and control of bias in the kidney disease outcomes quality initiative guideline development process.
    Van Wyck D; Eckardt KU; Uhlig K; Rocco M; Levin A
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):8-10. PubMed ID: 17699378
    [No Abstract]   [Full Text] [Related]  

  • 37. Challenges for nephrology nurses in the management of children with chronic kidney disease.
    Miller D; Macdonald D; Kolnacki K; Simek T
    Nephrol Nurs J; 2004; 31(3):287-94; quiz 295-6. PubMed ID: 15303424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caring for patients with chronic kidney disease: a joint opinion of the ambulatory care and the nephrology practice and research networks of the American College of Clinical Pharmacy.
    Zillich AJ; Saseen JJ; Dehart RM; Dumo P; Grabe DW; Gilmartin C; Hachey DM; Hudson JQ; Pruchnicki MC; Joy MS;
    Pharmacotherapy; 2005 Jan; 25(1):123-43. PubMed ID: 15767229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic kidney disease: what's in a name?
    Ridley J; Baker J; Mills C; Murray MA; Ton E
    CANNT J; 2009; 19(2):19-22. PubMed ID: 19606648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practice guidelines: are they dead on arrival? No, but...
    Golper T
    Nephrol News Issues; 2003 Oct; 17(11):40-1. PubMed ID: 14593819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.